# Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

> **NCT03485976** · PHASE2 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 12 (actual)

## Conditions studied

- Pityriasis Rubra Pilaris

## Interventions

- **DRUG:** Ixekizumab

## Key facts

- **NCT ID:** NCT03485976
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-23
- **Primary completion:** 2019-10-14
- **Final completion:** 2020-01-13
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03485976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03485976, "Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03485976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*